Page last updated: 2024-09-03

cholestyramine resin and colestipol

cholestyramine resin has been researched along with colestipol in 133 studies

Compound Research Comparison

Studies (cholestyramine resin)	Trials (cholestyramine resin)	Recent Studies (post-2010) (cholestyramine resin)	Studies (colestipol)	Trials (colestipol)	Recent Studies (post-2010) (colestipol)
2,669	342	190	399	110	16

Research

Studies (133)

Timeframe	Studies, this research(%)	All Research%
pre-1990	76 (57.14)	18.7374
1990's	40 (30.08)	18.2507
2000's	8 (6.02)	29.6817
2010's	7 (5.26)	24.3611
2020's	2 (1.50)	2.80

Authors

Authors	Studies
Beckers, C; Desager, JP; Harvengt, C; Leonard, JP	1
Bartlett, JG; Chang, TW; Onderdonk, AB	1
Burdon, DW; George, RH; Johnson, EM; Youngs, DJ	1
Blanke, RV; Fariss, MW; Guzelian, PS; Skalsky, HL	1
Heimann, KW; Stein, EA	1
Heuck, CC; Mordasini, R; Oster, P; Raetzer, H; Schellenberg, B; Schlierf, G; Twelsiek, F	1
Vogelberg, KH	1
Grundy, SM	1
Levy, RI	2
Martz, BL	1
Mertz, DP	1
Peters, U	1
Sattler, RW; Schmiedeberg, W; Seiler, KU	1
Fleischmajer, R	1
Augustin, J; Greten, H; Klose, G; Middelhoff, G; Mordasini, R	1
Heuck, CC; Mordasini, R; Oster, P; Raetzer, H; Schellenberg, B; Schlierf, G; Twelsick, F	1
Davison, KL; Sell, JL	1
Fraser, DG; Ludden, TM	1
Cocuzza, E; Conti, F; De Simone, R; Lovati, MR; Sirtori, CR; Sirtori, M	1
Faergeman, O; Thale, M	1
Hanefeld, M	1
Fallat, RW; Glueck, CJ; Mellies, MJ; Tsang, RC	1
Phillips, WA; Ratchford, JM; Schultz, JR	1
Gotto, AM; Yeshurun, D	1
McGurrey, E	1
McIntyre, TH; Shapiro, ML; Whitney, EJ; Wirebaugh, SR	1
Brown, GR; St-Pierre, LE; Zhu, XX	1
Chaudhary, A; Herman, RJ	1
Ito, MK; Morreale, AP	1
Angelin, B; Einarsson, K; Ericsson, S; Ewerth, S; Reihnér, E; Rudling, M; Ståhlberg, D	1
D'Amico, G; Gentile, MG	1
Eisenberg, JM; Glick, H; Jacobson, TA; Kinosian, B; Koffer, H; Schulman, KA; Willian, MK	1
Ast, M; Frishman, WH	1
Ariano, RE; Harding, GK; Zhanel, GG	1
Demacker, PN; Mol, MJ; Stalenhoef, AF; Stuyt, PM	1
al-Shareef, AH; Allen, EM; Buss, DC; Routledge, PA	1
Day, CE	1
Cuthbert, JA; East, CA; Lipsky, PE	1
LaRosa, J	1
Kivistö, KT; Neuvonen, PJ	1
Anding, RH; Lueg, MC	1
Eisenberg, JM; Kinosian, BP	1
Houlston, R; Lewis, B; Quiney, J; Watts, GF	1
Kane, JP; Malloy, MJ	2
Naito, HK	1
Stein, EA	1
Hirvisalo, EL; Kivistö, K; Neuvonen, PJ	1
Davignon, J	1
Blum, CB; Levy, RI	1
Nikkilä, EA; Tikkanen, MJ	1
Havel, RJ; Kane, JP	2
Gotto, AM; Jones, PH; Scott, LW	1
Dine, M; Glueck, CJ; Laskarzewski, P; Mellies, MJ; Perry, T	1
Packard, CJ; Shepherd, J	1
Crouse, JR	1
Jacobs, EW; Jungnickel, PW; Maloley, PA; Shaefer, MS	1
Levy, RI; Schaefer, EJ	1
Stamler, J	2
Amin, NM	1
Parker, F	1
Hibbard, DM; Hunninghake, DB; Peters, JR	1
Nash, DT	1
Glueck, CJ	1
Farinaro, E; Mancini, M; Montefusco, S; Postiglione, A	1
Kuo, PT	1
Canzler, H	1
Faruqui, AM; Thurmond, MS; Wenger, J; Wenger, NK	1
Brown, WJ; Hagerman, LM; Karr, JP; McGarry, M; Murphy, GP; Williams, PD	1
Callaghan, JT; Holtzman, JL; Hunninghake, DB; Tsuru, M	1
Wirth, KE	1
Herlihy, KJ; Powell, DW; Saco, LS	1
Tedesco, FJ	1
Azarnoff, DL; Saunders, RN	1
Hunninghake, DB; King, S; LaCroix, K	1
Kolb, S; Sailer, D	1
Bartlett, JG; Taylor, NS	1
Cassidy, MM; Grau, LE; Kritchevsky, D; Lightfoot, FG; Roy, T; Story, JA; Vahouny, GV	1
Comai, K; Sullivan, AC	1
Samuel, P	1
Olbricht, CJ	1
Ginsberg, HN	1
Chin, MM; Jozefiak, E; Morales, E; Spinler, SA; Wilson, MD	1
Farmer, JA; Gotto, AM	2
Davies, G; Kitano, Y; Maher, VM; Matthews, S; Mir, A; Neuwirth, C; Prescott, RJ; Rees, A; Shortt, MB; Thompson, GR	1
Hopman, WP; Jansen, JB; Lamers, CB; Rosenbusch, G; Sloots, CE; Tangerman, A; Thimister, PW; Willems, HL	1
al-Balla, SR; al-Meshal, MA; el-Sayed, YM; Gouda, MW	2
Florkowski, CM; Scott, RS	1
al-Angary, AA; al-Meshal, MA; el-Sayed, YM; Gouda, MW; Lutfi, KM	1
Reichen, J	1
Campbell, JR; Goris, GB; Jungnickel, PW; Maloley, PA; Oliphant, TH; Shaefer, MS; Shawaryn, GG	1
McKenney, JM	1
Coates, PM; Cortner, JA; Jarvik, GP; Liacouras, CA	1
Benson, GM; Blanchard, S; Ellis, D; Haynes, C	1
Bacon, S; Illingworth, DR; Mahley, RW; Schmidt, EB; Weisgraber, KH	1
Davidson, C; Davidson, D; Iversen, SA	1
Ose, L; Tonstad, S	1
Abdullah, ME; El-Sayed, YM	1
Bambauer, R; Müller, UA; Schiel, R	1
Knight, BL; Patel, DD; Soutar, AK; Sun, XM	1
Oster, G; Thompson, D	1
Chang, RK; Hussain, MA; McCormick, TJ; McCummings, T; Pang, J; Ramos, M; Wu, LS	1
Abrahamsson, H; Gillberg, R; Kilander, A; Ung, KA	1
Bourbon, M; Knight, BL; Naoumova, RP; Neuwirth, CK; O'Neill, FH; Patel, DD; Soutar, AK; Taylor, GW; Thompson, GR	1
Steinmetz, KL	1
Bouzamondo, A; Corvol, JC; Hulot, JS; Lechat, P; Sanchez, P; Sirol, M	1
Ballantyne, CM; Chiou, P; Guyton, JR; Jones, PH; Stein, JL; Xydakis, AM	1
Ritter, MM	1
Kuipers, F; Staels, B	1
Handelsman, Y	1
Danley, T; St Anna, L	1
Barkun, AN; Gould, M; Love, J; Pluta, H; Steinhart, H	1
Arnold, CA; Arnold, MA; Crowder, CD; Frankel, WL; Lam-Himlin, D; Singhi, AD; Stanich, PP; Swanson, BJ	1
Gleeson, JT; Kurien, M; Lin, S; Messham, L; Osborne, C; Sanders, DS	1
Aungst, A; Casady, L; Dixon, C; Maldonado, J; McCoy, B; Moreo, N; Robertson, D	1
Cai, T; Can, A; Castro, VM; Dligach, D; Du, R; Finan, S; Gainer, V; Murphy, S; Savova, G; Shadick, NA; Weiss, ST; Yu, S	1
Camilleri, M; Vijayvargiya, P	1
Harmsen, WS; Kamboj, AK; Khanna, S; Pardi, DS; Sehgal, K; Tome, J	1

Reviews

34 review(s) available for cholestyramine resin and colestipol

Article	Year
[Lipid-lowering drugs. Therapeutics and adverse effects]. Medizinische Klinik, 1979, Aug-10, Volume: 74, Issue:32-33 Topics: Arteriosclerosis; Child; Cholelithiasis; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, LDL; Lipoproteins, VLDL; Nicotinic Acids; Phenoxyacetates; Sitosterols	1979
Treatment of hypercholesterolemia. The American journal of clinical nutrition, 1977, Volume: 30, Issue:6 Topics: Animals; Arteriosclerosis; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Diet, Reducing; Dietary Fats; Fats, Unsaturated; Humans; Hypercholesterolemia; Ileum; Intestinal Absorption; Nicotinic Acids; Triglycerides	1977
The effect of hypolipidemic drugs on plasma lipoproteins. Annual review of pharmacology and toxicology, 1977, Volume: 17 Topics: Aminosalicylic Acid; Animals; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Dogs; Drug Therapy, Combination; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Neomycin; Nicotinic Acids; Rats; Sitosterols	1977
Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management. JAMA, 1990, Dec-19, Volume: 264, Issue:23 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Cost-Benefit Analysis; Drug Therapy, Combination; Gemfibrozil; Humans; Hypercholesterolemia; Lovastatin; Niacin; Probucol; Sensitivity and Specificity	1990
Bile acid sequestrants. Journal of clinical pharmacology, 1990, Volume: 30, Issue:2 Topics: Chemical Phenomena; Chemistry; Child; Child, Preschool; Cholestyramine Resin; Colestipol; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Lipoproteins, VLDL; Polyamines; Resins, Plant	1990
Review of clinical studies of bile acid sequestrants for lowering plasma lipid levels. Cardiology, 1989, Volume: 76 Suppl 1 Topics: Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Gastrointestinal Diseases; Humans; Hyperlipidemias; Polyamines	1989
Bile acid sequestrants and hyperlipidaemia. Lancet (London, England), 1988, Jan-30, Volume: 1, Issue:8579 Topics: Cholestyramine Resin; Colestipol; Humans; Hyperlipidemias; Lipoproteins, LDL; Polyamines	1988
When to treat hyperlipidemia. Advances in internal medicine, 1988, Volume: 33 Topics: Animals; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Neomycin; Niacin; Pentanoic Acids; Risk Factors; Triglycerides	1988
Reducing cardiac deaths with hypolipidemic drugs. Postgraduate medicine, 1987, Nov-01, Volume: 82, Issue:6 Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Feeding Behavior; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins, LDL; Niacin; Patient Education as Topic; Pentanoic Acids; Probucol	1987
Treatment of hypercholesterolemia. Annual review of medicine, 1986, Volume: 37 Topics: Animals; Cholestyramine Resin; Clofibrate; Colestipol; Cricetinae; Dogs; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Mice; Middle Aged; Neomycin; Niacin; Pentanoic Acids; Pregnancy; Probucol; Rats	1986
The diagnosis and management of hyperlipidemia. Disease-a-month : DM, 1986, Volume: 32, Issue:5 Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dietary Fats; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipoproteins; Lipoproteins, LDL; Neomycin; Niacin; Pentanoic Acids; Probucol; Receptors, LDL; Triglycerides	1986
Pharmacological modification of lipoprotein metabolism. Biochemical Society transactions, 1987, Volume: 15, Issue:2 Topics: Animals; Bile Acids and Salts; Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Intestinal Absorption; Lipoproteins; Niacin; Sterols	1987
Pathogenesis and management of lipoprotein disorders. The New England journal of medicine, 1985, May-16, Volume: 312, Issue:20 Topics: Abetalipoproteinemia; Adolescent; Adult; Aged; Child; Child, Preschool; Cholestyramine Resin; Chylomicrons; Colestipol; Dietary Fats; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Hyperlipoproteinemias; Hypobetalipoproteinemias; Hypolipoproteinemias; Infant; Infant, Newborn; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Niacin; Pentanoic Acids; Probucol; Tangier Disease	1985
Review of primary prevention trials of coronary heart disease. Acta medica Scandinavica. Supplementum, 1985, Volume: 701 Topics: Adult; Aged; Anticholesteremic Agents; Blood Pressure; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dietary Fats; Electrocardiography; Humans; Male; Middle Aged; Physical Exertion; Risk; Smoking Prevention; Stress, Psychological	1985
[Drug interactions in the use of cardiac glycosides]. Die Medizinische Welt, 1981, Feb-13, Volume: 32, Issue:7 Topics: Blood Proteins; Cardiac Glycosides; Charcoal; Cholestyramine Resin; Colestipol; Drug Interactions; Humans; Intestinal Absorption; Magnesium; Protein Binding; Quinidine; Receptors, Drug; Thyroid Hormones; Tissue Distribution	1981
Pseudomembranous (antibiotic-associated) colitis. Journal of the American Academy of Dermatology, 1981, Volume: 4, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Toxins; Cholestyramine Resin; Clostridium; Colestipol; Colon; Enterocolitis, Pseudomembranous; Humans; Prognosis; Vancomycin	1981
Treatment of hypercholesterolemia. The Medical clinics of North America, 1982, Volume: 66, Issue:2 Topics: Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Heterozygote; Homozygote; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols; Thyroxine	1982
Pseudomembranous colitis: pathogenesis and therapy. The Medical clinics of North America, 1982, Volume: 66, Issue:3 Topics: Anti-Bacterial Agents; Atropine; Bacitracin; Botulinum Toxins; Cholestyramine Resin; Clostridium; Clostridium Infections; Colestipol; Diphenoxylate; Drug Combinations; Enterocolitis, Pseudomembranous; Gastrointestinal Agents; Humans; Intestinal Mucosa; Metronidazole; Vancomycin	1982
Therapy of hyperlipidemic states. Annual review of medicine, 1982, Volume: 33 Topics: Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Colestipol; Dietary Fats; Drug Therapy, Combination; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Lipoproteins, LDL; Lipoproteins, VLDL; Niacin; Nicotinic Acids; Sitosterols	1982
Current status of drugs used to treat hyperlipoproteinemias. Drug therapeutics, 1982 Topics: Aminosalicylic Acid; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Enzyme Induction; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols	1982
Update on the treatment of hypercholesterolemia, with a focus on HMG-CoA reductase inhibitors and combination regimens. Clinical cardiology, 1995, Volume: 18, Issue:6 Topics: Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Coronary Disease; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Niacin	1995
Antihyperlipidaemic agents. Drug interactions of clinical significance. Drug safety, 1994, Volume: 11, Issue:5 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibric Acid; Colestipol; Drug Interactions; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Niacin; Probucol	1994
Noninsulin dependent diabetes mellitus: the importance of dyslipidaemia. The New Zealand medical journal, 1994, Apr-27, Volume: 107, Issue:976 Topics: Cholestyramine Resin; Colestipol; Contraindications; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Hyperlipidemias; Hypertriglyceridemia; Hypolipidemic Agents	1994
Pharmacologic treatment of cholestasis. Seminars in liver disease, 1993, Volume: 13, Issue:3 Topics: Cholestasis; Cholestyramine Resin; Colestipol; Enzyme Induction; Humans; Pruritus; S-Adenosylmethionine; Ursodeoxycholic Acid	1993
Familial combined hyperlipidemia in children: clinical expression, metabolic defects, and management. The Journal of pediatrics, 1993, Volume: 123, Issue:2 Topics: Adolescent; Apolipoproteins B; Child; Child, Preschool; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Energy Intake; Female; Genetic Linkage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Lipoproteins, VLDL; Liver; Male; Multigene Family; Niacin; Phenotype; Polymorphism, Genetic; Triglycerides	1993
Choosing the right lipid-regulating agent. A guide to selection. Drugs, 1996, Volume: 52, Issue:5 Topics: Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Niacin; Triglycerides	1996
Cost-effectiveness of drug therapy for hypercholesterolaemia: a review of the literature. PharmacoEconomics, 1992, Volume: 2, Issue:1 Topics: Age Factors; Cholestyramine Resin; Colestipol; Coronary Disease; Cost-Benefit Analysis; Humans; Hypercholesterolemia; Lovastatin; Risk Factors; Sex Factors; Treatment Outcome	1992
Colesevelam hydrochloride. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2002, May-15, Volume: 59, Issue:10 Topics: Allylamine; Cholestyramine Resin; Colesevelam Hydrochloride; Colestipol; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hypolipidemic Agents	2002
Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials. Archives of internal medicine, 2003, Mar-24, Volume: 163, Issue:6 Topics: Anticholesteremic Agents; Atorvastatin; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Myocardial Infarction; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Regression Analysis; Risk Assessment; Risk Factors; Simvastatin; Stroke; Treatment Failure; Treatment Outcome	2003
Bile acid sequestrants and the treatment of type 2 diabetes mellitus. Drugs, 2007, Volume: 67, Issue:10 Topics: Allylamine; Animals; Bile Acids and Salts; Cholestyramine Resin; Clinical Trials as Topic; Colesevelam Hydrochloride; Colestipol; Diabetes Mellitus, Type 2; DNA-Binding Proteins; Glucose; Glycated Hemoglobin; Humans; Hypolipidemic Agents; Lipid Metabolism; Receptors, Cytoplasmic and Nuclear; Transcription Factors	2007
Role of bile acid sequestrants in the treatment of type 2 diabetes. Diabetes care, 2011, Volume: 34 Suppl 2 Topics: Allylamine; Bile Acids and Salts; Cholestyramine Resin; Colesevelam Hydrochloride; Colestipol; Diabetes Mellitus, Type 2; Epichlorohydrin; Hypolipidemic Agents; Imidazoles; Resins, Synthetic	2011
Clinical inquiry. Postcholecystectomy diarrhea: what relieves it? The Journal of family practice, 2011, Volume: 60, Issue:10 Topics: Anion Exchange Resins; Bile Acids and Salts; Cholecystectomy; Cholestyramine Resin; Colestipol; Diarrhea; Humans; Malabsorption Syndromes	2011
Bile acid malabsorption in chronic diarrhea: pathophysiology and treatment. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2013, Volume: 27, Issue:11 Topics: Allylamine; Animals; Anion Exchange Resins; Bile Acids and Salts; Cholestyramine Resin; Chronic Disease; Colesevelam Hydrochloride; Colestipol; Diarrhea; Humans; Malabsorption Syndromes; Practice Guidelines as Topic; Prevalence	2013
The Role of Bile Acids in Chronic Diarrhea. The American journal of gastroenterology, 2020, Volume: 115, Issue:10 Topics: Benzothiazoles; Bile Acids and Salts; Chenodeoxycholic Acid; Cholestenones; Cholestyramine Resin; Chronic Disease; Colesevelam Hydrochloride; Colestipol; Diarrhea; Diet, Fat-Restricted; Feces; Humans; Intestinal Mucosa; Irritable Bowel Syndrome; Isoxazoles; Liver; Malabsorption Syndromes; Receptors, Cytoplasmic and Nuclear; Sequestering Agents; Taurocholic Acid	2020

Trials

21 trial(s) available for cholestyramine resin and colestipol

Article	Year
Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1975, Jul-19, Volume: 49, Issue:31 Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Lipoproteins, LDL; Male; Middle Aged; Placebos; Polyamines; Triglycerides	1975
Abnormal low density lipoproteins in children with familial hypercholesterolemia--effect of polyanion exchange resins. Klinische Wochenschrift, 1978, Aug-15, Volume: 56, Issue:16 Topics: Adolescent; Apolipoproteins; Child; Cholesterol; Cholestyramine Resin; Colestipol; Female; Humans; Ion Exchange Resins; Lipid Metabolism, Inborn Errors; Lipoproteins, LDL; Male; Phospholipids; Triglycerides	1978
Pharmacological and dietary treatment of lipid abnormalities in nephrotic patients. Kidney international. Supplement, 1991, Volume: 31 Topics: Cholestyramine Resin; Colestipol; Food, Formulated; Gemfibrozil; Humans; Hyperlipidemias; Lipids; Lovastatin; Nephrotic Syndrome; Probucol	1991
The role of anion-exchange resins in the treatment of antibiotic-associated pseudomembranous colitis. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1990, May-15, Volume: 142, Issue:10 Topics: Adult; Anion Exchange Resins; Child; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Ion Exchange Resins; Metronidazole; Vancomycin	1990
Review of clinical studies of bile acid sequestrants for lowering plasma lipid levels. Cardiology, 1989, Volume: 76 Suppl 1 Topics: Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Gastrointestinal Diseases; Humans; Hyperlipidemias; Polyamines	1989
Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide. British journal of clinical pharmacology, 1988, Volume: 25, Issue:2 Topics: Adult; Anion Exchange Resins; Carbamazepine; Charcoal; Cholestyramine Resin; Colestipol; Digoxin; Female; Furosemide; Humans; Intestinal Absorption; Ion Exchange Resins; Male	1988
Acceptability of cholestyramine or colestipol combinations with six vehicles. Clinical pharmacy, 1987, Volume: 6, Issue:1 Topics: Adult; Beverages; Cholestyramine Resin; Colestipol; Female; Humans; Male; Pharmaceutical Vehicles; Polyamines; Water	1987
Review of primary prevention trials of coronary heart disease. Acta medica Scandinavica. Supplementum, 1985, Volume: 701 Topics: Adult; Aged; Anticholesteremic Agents; Blood Pressure; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dietary Fats; Electrocardiography; Humans; Male; Middle Aged; Physical Exertion; Risk; Smoking Prevention; Stress, Psychological	1985
Pharmacological trials: primary and secondary prevention of coronary heart disease. Preventive medicine, 1983, Volume: 12, Issue:1 Topics: Aspirin; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dipyridamole; Estrogens; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Sulfinpyrazone	1983
Current status of drugs used to treat hyperlipoproteinemias. Drug therapeutics, 1982 Topics: Aminosalicylic Acid; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Enzyme Induction; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols	1982
Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis. Lancet (London, England), 1995, Apr-01, Volume: 345, Issue:8953 Topics: Adult; Blood Component Removal; Cholestyramine Resin; Colestipol; Coronary Angiography; Coronary Artery Disease; Data Interpretation, Statistical; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Lipids; Lipoprotein(a); Lipoproteins, LDL; Lovastatin; Middle Aged; Odds Ratio; Simvastatin	1995
The effects of cholestyramine and colestipol on the absorption of diclofenac in man. International journal of clinical pharmacology and therapeutics, 1994, Volume: 32, Issue:8 Topics: Absorption; Adsorption; Adult; Analysis of Variance; Blood Specimen Collection; Cholestyramine Resin; Chromatography, High Pressure Liquid; Colestipol; Diclofenac; Double-Blind Method; Drug Interactions; Humans; Male	1994
The effect of colestipol and cholestyramine on ibuprofen bioavailability in man. Biopharmaceutics & drug disposition, 1994, Volume: 15, Issue:6 Topics: Absorption; Administration, Oral; Adult; Biological Availability; Cholestyramine Resin; Chromatography, High Pressure Liquid; Colestipol; Cross-Over Studies; Drug Interactions; Humans; Ibuprofen; Male; Software	1994
Blind comparison of patient preference for Flavored Colestid Granules and Questran Light. The Annals of pharmacotherapy, 1993, Volume: 27, Issue:6 Topics: Adult; Chemistry, Pharmaceutical; Cholestyramine Resin; Colestipol; Double-Blind Method; Humans; Middle Aged; Patient Satisfaction; Pharmaceutical Vehicles	1993
The acceptability of resin therapy to patients attending a hospital lipid clinic. British journal of clinical pharmacology, 1995, Volume: 40, Issue:1 Topics: Adolescent; Adult; Aged; Anion Exchange Resins; Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Cross-Over Studies; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Inpatients; Male; Middle Aged; Surveys and Questionnaires	1995
Design of crossover microcomputer program and application on drug bioequivalence data. Computer methods and programs in biomedicine, 1995, Volume: 48, Issue:3 Topics: Analysis of Variance; Anion Exchange Resins; Biological Availability; Cholestyramine Resin; Colestipol; Cross-Over Studies; Drug Interactions; Drug Therapy, Combination; Humans; Ibuprofen; Male; Microcomputers; Software Design; Therapeutic Equivalency	1995
Four years' treatment efficacy of patients with severe hyperlipidemia. Lipid lowering drugs versus LDL-apheresis. The International journal of artificial organs, 1995, Volume: 18, Issue:12 Topics: Adolescent; Adult; Anticholesteremic Agents; Blood Component Removal; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Female; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Longitudinal Studies; Lovastatin; Male; Middle Aged; Niacin; Pravastatin; Quality of Life	1995
Influence of genotype at the low density lipoprotein (LDL) receptor gene locus on the clinical phenotype and response to lipid-lowering drug therapy in heterozygous familial hypercholesterolaemia. The Familial Hypercholesterolaemia Regression Study Group. Atherosclerosis, 1998, Volume: 136, Issue:1 Topics: Adult; Anticholesteremic Agents; Cholestyramine Resin; Colestipol; Female; Genotype; Heterozygote; Humans; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Male; Middle Aged; Phenotype; Receptors, LDL; Simvastatin	1998
Role of bile acids and bile acid binding agents in patients with collagenous colitis. Gut, 2000, Volume: 46, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Bile Acids and Salts; Cholestyramine Resin; Chronic Disease; Colestipol; Colitis; Collagen; Diarrhea; Female; Humans; Intestinal Absorption; Male; Middle Aged; Prospective Studies; Statistics, Nonparametric	2000
Determinants of variable response to statin treatment in patients with refractory familial hypercholesterolemia. Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:5 Topics: Anticholesteremic Agents; Atorvastatin; Cholestenones; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl CoA Reductases; Hyperlipoproteinemia Type II; Male; Mevalonic Acid; Middle Aged; Mutation; Pyrroles; Receptors, LDL; RNA, Messenger	2001
Tolerability and efficacy of colestipol hydrochloride for accelerated elimination of teriflunomide. Expert review of clinical pharmacology, 2017, Volume: 10, Issue:12 Topics: Adolescent; Adult; Anion Exchange Resins; Cholestyramine Resin; Colestipol; Crotonates; Female; Humans; Hydroxybutyrates; Male; Nitriles; Sequestering Agents; Toluidines; Treatment Outcome; Young Adult	2017

Other Studies

81 other study(ies) available for cholestyramine resin and colestipol

Article	Year
In vitro binding of various biological substances by two hypocholesterolaemic resins. Cholestyramine and colestipol. Arzneimittel-Forschung, 1979, Volume: 29, Issue:7 Topics: Body Fluids; Calcium; Chemical Phenomena; Chemistry; Cholestyramine Resin; Colestipol; Duodenum; Folic Acid; Gastric Juice; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Iron; Polyamines; Vitamin B 12	1979
Anion-exchange resins in antibiotic-associated colitis. Lancet (London, England), 1978, Jul-29, Volume: 2, Issue:8083 Topics: Anti-Bacterial Agents; Bacterial Toxins; Cholestyramine Resin; Colestipol; Colitis; Humans; Polyamines	1978
Anion-exchange resins in pseudomembranous colitis. Lancet (London, England), 1978, Sep-16, Volume: 2, Issue:8090 Topics: Anion Exchange Resins; Binding Sites; Cholestyramine Resin; Colestipol; Drug Evaluation; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; In Vitro Techniques; Intestinal Absorption; Ion Exchange Resins; Polyamines; Vancomycin	1978
The role of plasma proteins in the transport and distribution of chlordecone (Kepone) and other polyhalogenated hydrocarbons. Annals of the New York Academy of Sciences, 1979, May-31, Volume: 320 Topics: Animals; Carrier Proteins; Chlordecone; Cholestyramine Resin; Colestipol; Environmental Exposure; Humans; Insecticides; Lipoproteins; Male; Methods; Rats; Resins, Plant	1979
Drug management of hypercholesterolemia. American heart journal, 1979, Volume: 97, Issue:3 Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hypercholesterolemia; Nicotinic Acids; Probucol; Sitosterols	1979
[Antilipemic agents available after the ban on clofibrate: clinical-pharmacological view]. Fortschritte der Medizin, 1979, Apr-19, Volume: 97, Issue:15 Topics: Cholestyramine Resin; Clofibrate; Colestipol; Germany, West; Humans; Hyperlipidemias; Hypolipidemic Agents; Legislation, Drug; Nicotinic Acids; Sitosterols; Thyroxine	1979
[Anticoagulant therapy: consideration of use and costs]. Deutsche medizinische Wochenschrift (1946), 1979, Sep-14, Volume: 104, Issue:37 Topics: Anticoagulants; Cholestyramine Resin; Colestipol; Costs and Cost Analysis; Drug Interactions; Humans; Pyrazoles	1979
[Modification-possibility of the enterohepatic circulation of digitoxin in man]. Arzneimittel-Forschung, 1977, Volume: 27, Issue:8 Topics: Cholestyramine Resin; Colestipol; Digitoxin; Female; Humans; Intestinal Absorption; Intestinal Mucosa; Liver; Male; Middle Aged	1977
Hypolipidemic drugs. American family physician, 1978, Volume: 17, Issue:2 Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Probucol	1978
[Drug treatment of primary hyperlipoproteinemia (author's transl)]. Klinische Wochenschrift, 1978, Feb-01, Volume: 56, Issue:3 Topics: Anion Exchange Resins; Biguanides; Cholestyramine Resin; Clofibrate; Colestipol; DEAE-Dextran; Dextrothyroxine; Drug Therapy, Combination; Estrogens; Humans; Hyperlipidemias; Lipoproteins; Neomycin; Nicotinic Acids; Progestins; Sitosterols	1978
[A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)]. Monatsschrift fur Kinderheilkunde, 1978, Volume: 126, Issue:7 Topics: Adolescent; Child; Cholesterol; Cholestyramine Resin; Colestipol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Male; Phospholipids; Polyamines	1978
Dieldrin-14C elimination from turkeys. Archives of environmental contamination and toxicology, 1978, Volume: 7, Issue:2 Topics: Aging; Animals; Charcoal; Cholestyramine Resin; Colestipol; Dieldrin; Feces; Lipid Metabolism; Male; Starvation; Turkeys	1978
Treatment of digoxin poisonings. American journal of hospital pharmacy, 1978, Volume: 35, Issue:9 Topics: Animals; Charcoal; Cholestyramine Resin; Colestipol; Digoxin; Hemoperfusion; Humans	1978
New microporous cholestyramine analog for treatment of hypercholesterolemia. Journal of pharmaceutical sciences, 1978, Volume: 67, Issue:12 Topics: Adult; Aged; Cholestyramine Resin; Cholic Acids; Colestipol; Constipation; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Suspensions	1978
Binding of bile acids to anion-exchanging drugs in vitro. Scandinavian journal of gastroenterology, 1978, Volume: 13, Issue:3 Topics: Acacia; Anion Exchange Resins; Bile Acids and Salts; Cholestyramine Resin; Colestipol; DEAE-Dextran; Dextrans; Drug Combinations; Humans; In Vitro Techniques; Ion Exchange Resins	1978
Hypolipidemic agents and gallstones. The Medical letter on drugs and therapeutics, 1977, Jun-03, Volume: 19, Issue:11 Topics: Cholelithiasis; Cholestyramine Resin; Clofibrate; Colestipol; Humans; Polyamines	1977
[Drug treatment of hyperlipoproteinemias]. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1977, May-01, Volume: 32, Issue:9 Topics: Cholestasis; Cholestyramine Resin; Clofibrate; Colestipol; Erectile Dysfunction; Female; Humans; Hyperlipidemias; Male; Nicotinic Acids	1977
Treatment of hyperlipidemias in childhood. Advances in experimental medicine and biology, 1977, Volume: 82 Topics: Adolescent; Child; Child, Preschool; Cholestyramine Resin; Colestipol; Humans; Hypercholesterolemia; Hyperlipidemias; Infant; Infant, Newborn; Triglycerides	1977
Drug therapy of hyperlipoproteinemia. JAMA, 1976, May-24, Volume: 235, Issue:21 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Drug Therapy, Combination; Humans; Hyperlipidemias; Nicotinic Acids; Sitosterols	1976
Effects of colestipol hydrochloride on drug absorption in the rat II. Journal of pharmaceutical sciences, 1976, Volume: 65, Issue:9 Topics: Animals; Cellulose; Chlorpromazine; Cholestyramine Resin; Clofibrate; Colestipol; Digitoxin; Digoxin; Hydrochlorothiazide; Intestinal Absorption; Male; Nicotinic Acids; Pharmaceutical Preparations; Phenobarbital; Polyamines; Rats; Tetracycline; Warfarin	1976
Drug treatment of hyperlipidemia. The American journal of medicine, 1976, Volume: 60, Issue:3 Topics: Aminosalicylic Acids; Anabolic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Estrogens; Halofenate; Humans; Hyperlipidemias; Neomycin; Nicotinic Acids; Progesterone; Sitosterols	1976
Ask the Pharmacist. American pharmacy, 1992, Volume: NS32, Issue:9 Topics: Cholestyramine Resin; Colestipol; Enterocolitis, Pseudomembranous; Humans; Vancomycin	1992
A retrospective review of the use of lipid-lowering agents in combination, specifically, gemfibrozil and lovastatin. Pharmacotherapy, 1992, Volume: 12, Issue:6 Topics: Aged; Alanine Transaminase; Cholestyramine Resin; Colestipol; Creatine Kinase; Drug Interactions; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Lipids; Lovastatin; Male; Middle Aged; Niacin; Retrospective Studies	1992
Polymeric sorbents for bile acids. I: Comparison between cholestyramine and colestipol. Journal of pharmaceutical sciences, 1992, Volume: 81, Issue:1 Topics: Absorption; Bile Acids and Salts; Buffers; Cholestyramine Resin; Cholic Acid; Cholic Acids; Colestipol; Mathematics; Temperature	1992
In vitro binding of lorazepam and lorazepam glucuronide to cholestyramine, colestipol, and activated charcoal. Pharmaceutical research, 1991, Volume: 8, Issue:4 Topics: Adsorption; Charcoal; Cholestyramine Resin; Colestipol; Kinetics; Lorazepam	1991
Choice of cholesterol-lowering drugs. The Medical letter on drugs and therapeutics, 1991, Jan-11, Volume: 33, Issue:835 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Lovastatin; Neomycin; Niacin; Probucol	1991
Acceptability of cholestyramine and colestipol formulations in three common vehicles. Clinical pharmacy, 1991, Volume: 10, Issue:2 Topics: Adult; Chemistry, Pharmaceutical; Cholestyramine Resin; Colestipol; Double-Blind Method; Evaluation Studies as Topic; Female; Humans; Hypercholesterolemia; Male; Prospective Studies; Random Allocation; Taste	1991
Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolism. European journal of clinical pharmacology, 1991, Volume: 40 Suppl 1 Topics: Bile; Bile Acids and Salts; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cholestyramine Resin; Colestipol; Enterohepatic Circulation; Humans; Lipoproteins	1991
Therapy for hypercholesterolemia; standardization of cholesterol measurements. JAMA, 1990, Jan-19, Volume: 263, Issue:3 Topics: Cholesterol; Cholestyramine Resin; Colestipol; Drug Interactions; Humans; Hypercholesterolemia; Reference Standards; Thyroid Function Tests	1990
The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia. The Netherlands journal of medicine, 1990, Volume: 36, Issue:3-4 Topics: Adult; Apolipoproteins; Cholesterol; Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipoproteins; Lovastatin; Male; Middle Aged; Simvastatin; Triglycerides	1990
The effects of charcoal and sorbitol (alone and in combination) on plasma theophylline concentrations after a sustained-release formulation. Human & experimental toxicology, 1990, Volume: 9, Issue:3 Topics: Adult; Aminophylline; Biological Availability; Charcoal; Cholestyramine Resin; Colestipol; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Sorbitol; Theophylline; Time Factors	1990
Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail. Artery, 1990, Volume: 17, Issue:5 Topics: Animals; Arteriosclerosis; Bile Acids and Salts; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Colestipol; Coturnix; Diet, Atherogenic; Disease Models, Animal; Hypercholesterolemia; Male; Polyamines; Therapeutic Equivalency	1990
Normalization of LDL receptor function by lymphocytes of patients with heterozygous familial hypercholesterolemia after treatment with plasma cholesterol lowering agents. The American journal of the medical sciences, 1989, Volume: 298, Issue:3 Topics: Anticholesteremic Agents; Cholestyramine Resin; Colestipol; Drug Combinations; Heterozygote; Humans; Hyperlipoproteinemia Type II; Lipoproteins; Lipoproteins, LDL; Lovastatin; Lymphocytes; Receptors, Cell Surface; Receptors, Lipoprotein; Reference Values	1989
Activated charcoal should replace the resins in the treatment of digoxin intoxication! Archives of internal medicine, 1989, Volume: 149, Issue:11 Topics: Charcoal; Cholestyramine Resin; Colestipol; Digoxin; Humans	1989
Hypercholesterolemia: new values, new strategies. Hospital practice (Office ed.), 1986, Jan-30, Volume: 21, Issue:1A Topics: Cholesterol; Cholesterol, HDL; Cholestyramine Resin; Colestipol; Coronary Disease; Energy Intake; Female; Humans; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Niacin	1986
Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia. JAMA, 1988, Apr-15, Volume: 259, Issue:15 Topics: Cholestyramine Resin; Colestipol; Coronary Disease; Cost-Benefit Analysis; Edible Grain; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Office Visits; Polyamines; Smoking	1988
Gemfibrozil in the treatment of resistant familial hypercholesterolaemia and type III hyperlipoproteinaemia. Journal of the Royal Society of Medicine, 1988, Volume: 81, Issue:5 Topics: Cholesterol; Cholesterol, HDL; Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hypolipidemic Agents; Male; Pentanoic Acids; Triglycerides; Valerates	1988
Drug therapy in children and adolescents with familial hypercholesterolemia. Progress in clinical and biological research, 1988, Volume: 255 Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Infant; Male; Niacin	1988
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel. Archives of internal medicine, 1988, Volume: 148, Issue:1 Topics: Adult; Aged; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Coronary Disease; Dietary Fats; Female; Gemfibrozil; Humans; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Male; Middle Aged; Niacin; Patient Compliance; Pentanoic Acids; Probucol; Risk Factors	1988
Medical management of hyperlipidemia and the role of probucol. The American journal of cardiology, 1986, Jun-27, Volume: 57, Issue:16 Topics: Adult; Arteriosclerosis; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Female; Gemfibrozil; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Niacin; Pentanoic Acids; Phenols; Probucol; Risk	1986
Rational drug therapy of the hyperlipoproteinemias, Part II. Rational drug therapy, 1986, Volume: 20, Issue:10 Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Female; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Neomycin; Niacin; Pentanoic Acids; Probucol	1986
Current pharmacologic treatment of elevated serum cholesterol. Circulation, 1987, Volume: 76, Issue:3 Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Drug Tolerance; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Probucol; Simvastatin; Triglycerides	1987
Safety and efficacy of long-term diet and diet plus bile acid-binding resin cholesterol-lowering therapy in 73 children heterozygous for familial hypercholesterolemia. Pediatrics, 1986, Volume: 78, Issue:2 Topics: Adolescent; Behavior; Bile Acids and Salts; Body Height; Body Weight; Child; Cholesterol; Cholestyramine Resin; Colestipol; Drug Evaluation; Evaluation Studies as Topic; Female; Follow-Up Studies; Heterozygote; Humans; Hyperlipoproteinemia Type II; Male; Polyamines; Sexual Maturation	1986
Hypertriglyceridemia: a contraindication to the use of bile acid binding resins. The American journal of medicine, 1987, Volume: 83, Issue:2 Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Drug Evaluation; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Polyamines; Time Factors; Triglycerides	1987
Lipid-lowering drugs. The Medical letter on drugs and therapeutics, 1985, Aug-30, Volume: 27, Issue:695 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins; Neomycin; Niacin; Pentanoic Acids; Probucol; Triglycerides	1985
Antibiotic-associated pseudomembranous colitis. American family physician, 1985, Volume: 31, Issue:5 Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacitracin; Bacterial Proteins; Bacterial Toxins; Cephalosporins; Cholestyramine Resin; Clindamycin; Clostridium; Colestipol; Endoscopy; Enterocolitis, Pseudomembranous; Feces; Humans; Leukocyte Count; Metronidazole; Vancomycin	1985
Xanthomas and hyperlipidemias. Journal of the American Academy of Dermatology, 1985, Volume: 13, Issue:1 Topics: Apoproteins; Arteriosclerosis; Cholestasis; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Diabetes Complications; Female; Humans; Hyperlipidemias; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Hypolipidemic Agents; Hypothyroidism; Kidney Diseases; Lipoproteins; Male; Neomycin; Niacin; Obesity; Pancreatitis; Xanthomatosis	1985
Effects of cholestyramine and colestipol on the plasma concentrations of propranolol. British journal of clinical pharmacology, 1984, Volume: 18, Issue:3 Topics: Adult; Biotransformation; Cholestyramine Resin; Colestipol; Drug Interactions; Humans; Kinetics; Male; Middle Aged; Polyamines; Propranolol	1984
Gemfibrozil in combination with other drugs for severe hyperlipidemia. Preliminary study comprising four cases. Postgraduate medicine, 1983, Volume: 73, Issue:4 Topics: Adult; Cholesterol; Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hyperlipidemias; Lipoproteins, HDL; Male; Middle Aged; Niacin; Pentanoic Acids; Probucol; Triglycerides; Valerates	1983
Therapy of familial and acquired hyperlipoproteinemia in children and adolescents. Preventive medicine, 1983, Volume: 12, Issue:6 Topics: Adolescent; Child; Child, Preschool; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Energy Intake; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Infant; Infant Food; Lipoproteins, LDL; Male; Patient Compliance; Triglycerides	1983
Diet, drugs, and plasma exchange in the treatment of hyperlipidemia in childhood. Preventive medicine, 1983, Volume: 12, Issue:6 Topics: Adolescent; Child; Child, Preschool; Cholesterol, Dietary; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Plasma Exchange; Polyamines	1983
Treating hyperlipidemia to provide salutary effect on coronary artery disease. Chest, 1984, Volume: 85, Issue:4 Topics: Arteriosclerosis; Cholestyramine Resin; Colestipol; Coronary Disease; Dietary Fats; Enzyme Inhibitors; Fatty Acids, Unsaturated; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Lipoproteins, LDL	1984
[Drug therapy of hypercholesterinemias (author's transl)]. MMW, Munchener medizinische Wochenschrift, 1980, Mar-28, Volume: 122, Issue:13 Topics: Adult; Bezafibrate; Cholestyramine Resin; Clofibric Acid; Colestipol; Dextrothyroxine; Fenofibrate; Humans; Hypercholesterolemia; Neomycin; Nicotinic Acids; Sitosterols	1980
Efficacy, tolerance, and safety of colestipol HCL as a hypocholesterolemic agent in hyperlipidemic patients with studies of its effect on gastrointestinal absorption. JPMA. The Journal of the Pakistan Medical Association, 1981, Volume: 31, Issue:11 Topics: Adult; Cholestyramine Resin; Colestipol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Intestinal Absorption; Male; Polyamines	1981
The effects of cholestyramine, colestipol, and ADR-132 on the rat prostate and dunning R-3327 adenocarcinoma. Journal of surgical oncology, 1983, Volume: 22, Issue:4 Topics: Adenocarcinoma; Animals; Anion Exchange Resins; Body Weight; Cholestyramine Resin; Colestipol; Ion Exchange Resins; Male; Neoplasms, Experimental; Organ Size; Polyamines; Prostatic Neoplasms; Rats; Rats, Inbred F344; Resins, Synthetic	1983
Effect of cholestyramine and colestipol on the absorption of phenytoin. European journal of clinical pharmacology, 1983, Volume: 24, Issue:5 Topics: Adolescent; Adult; Cholestyramine Resin; Colestipol; Drug Interactions; Half-Life; Humans; Intestinal Absorption; Male; Phenytoin; Polyamines	1983
The effect of cholestyramine and colestipol on the absorption of hydrochlorothiazide. International journal of clinical pharmacology, therapy, and toxicology, 1982, Volume: 20, Issue:4 Topics: Adolescent; Adult; Biological Availability; Cholestyramine Resin; Colestipol; Drug Interactions; Humans; Hydrochlorothiazide; Intestinal Absorption; Male; Polyamines	1982
[Treatment of coronary heart disease with diet and lipid-reducing agents]. Fortschritte der Medizin, 1982, Nov-18, Volume: 100, Issue:43 Topics: Adolescent; Adult; Child; Cholestyramine Resin; Clofibrate; Clofibric Acid; Colestipol; Coronary Disease; Dextrothyroxine; Humans; Hypolipidemic Agents; Nicotinic Acids; Risk	1982
Binding of Clostridium difficile cytotoxin and vancomycin by anion-exchange resins. The Journal of infectious diseases, 1980, Volume: 141, Issue:1 Topics: Absorption; Animals; Anion Exchange Resins; Anti-Bacterial Agents; Binding, Competitive; Cholestyramine Resin; Clindamycin; Clostridium; Colestipol; Cricetinae; Cytotoxins; Disease Models, Animal; Dose-Response Relationship, Drug; Enterocolitis, Pseudomembranous; Feces; Ion Exchange Resins; Male; Vancomycin	1980
Management of the hyperlipidaemias. Drug and therapeutics bulletin, 1980, Mar-28, Volume: 18, Issue:7 Topics: Cholestyramine Resin; Clofibrate; Colestipol; Female; Humans; Hyperlipidemias; Nicotinic Acids	1980
Effect of bile salt-binding resins on the morphology of rat jejunum and colon. A scanning electron microscopy study. Digestive diseases and sciences, 1980, Volume: 25, Issue:7 Topics: Animals; Anion Exchange Resins; Cholestyramine Resin; Colestipol; Colon; Intestinal Mucosa; Ion Exchange Resins; Jejunum; Male; Rats	1980
In vivo meal model for the evaluation of agents which affect the absorption of triglyceride and cholesterol. Biochemical pharmacology, 1980, Jun-01, Volume: 29, Issue:11 Topics: Animals; Cholesterol, Dietary; Cholestyramine Resin; Colestipol; Diet; Dietary Fats; Drug Evaluation, Preclinical; Female; Gastric Emptying; Intestinal Absorption; Models, Biological; Oils; Poloxalene; Rats; Time Factors; Triglycerides	1980
Lipid-lowering drugs. The Medical letter on drugs and therapeutics, 1980, Aug-08, Volume: 22, Issue:16 Topics: Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hypolipidemic Agents; Neomycin; Nicotinic Acids; Probucol	1980
Drug treatment of hyperlipidemia. American heart journal, 1980, Volume: 100, Issue:4 Topics: Adolescent; Adult; Child; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hyperlipidemias; Middle Aged; Neomycin; Nicotinic Acids; Probucol	1980
Low-density-lipoprotein apheresis. Lancet (London, England), 1995, Jul-08, Volume: 346, Issue:8967 Topics: Anticholesteremic Agents; Blood Component Removal; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Lovastatin; Simvastatin	1995
Criteria for use of hypolipidemic agents in adults. American journal of hospital pharmacy, 1994, Nov-15, Volume: 51, Issue:22 Topics: Adult; Anticholesteremic Agents; Cholestyramine Resin; Colestipol; Female; Gemfibrozil; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Niacin; Risk Factors	1994
Effect of bile salt binding or protease inactivation on plasma cholecystokinin and gallbladder responses to bombesin. Gastroenterology, 1994, Volume: 107, Issue:6 Topics: Adult; Bile Acids and Salts; Bombesin; Cholecystokinin; Cholestyramine Resin; Colestipol; Endopeptidases; Enzyme Activation; Esters; Feedback; Female; Gabexate; Gallbladder; Gastrins; Guanidines; Humans; Male; Middle Aged; Muscle Contraction; Muscle, Smooth; Protease Inhibitors; Protein Binding	1994
The effect of colestipol and cholestyramine on the systemic clearance of intravenous ibuprofen in rabbits. The Journal of pharmacy and pharmacology, 1994, Volume: 46, Issue:1 Topics: Administration, Oral; Adsorption; Animals; Cholestyramine Resin; Colestipol; Ibuprofen; In Vitro Techniques; Injections, Intravenous; Male; Rabbits	1994
New guidelines for managing hypercholesterolemia. National Cholesterol Education Program. American pharmacy, 1993, Volume: NS33, Issue:7 Topics: Algorithms; Anticholesteremic Agents; Cholestyramine Resin; Colestipol; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Oxidoreductases; Risk Factors	1993
In vitro studies to investigate the reasons for the low potency of cholestyramine and colestipol. Journal of pharmaceutical sciences, 1993, Volume: 82, Issue:1 Topics: Bile; Bile Acids and Salts; Cholestyramine Resin; Colestipol; Solubility	1993
Choice of cholesterol-lowering drugs. The Medical letter on drugs and therapeutics, 1993, Mar-05, Volume: 35, Issue:891 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Probucol	1993
Hypocholesterolemic effects of cholestyramine and colestipol in patients with familial defective apolipoprotein B-100. Atherosclerosis, 1993, Jan-25, Volume: 98, Issue:2 Topics: Adult; Aged; Apolipoprotein B-100; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Female; Heterozygote; Humans; Hyperlipoproteinemia Type II; Male; Middle Aged; Triglycerides	1993
The detection and management of dyslipidaemia in children and adolescents. Acta paediatrica (Oslo, Norway : 1992), 1995, Volume: 84, Issue:11 Topics: Adolescent; Anticholesteremic Agents; Child; Child, Preschool; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Diet Therapy; Female; Humans; Hyperlipidemias; Male	1995
Development of an unconventional in vitro drug release test method for a bile acid sequestrant, DMP 504, tablet. Pharmaceutical research, 1999, Volume: 16, Issue:7 Topics: Anticholesteremic Agents; Bile Acids and Salts; Calibration; Chemistry, Pharmaceutical; Cholestyramine Resin; Colestipol; Hypolipidemic Agents; Linear Models; Polymers; Quaternary Ammonium Compounds; Tablets	1999
Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia. The American journal of cardiology, 2004, Sep-15, Volume: 94, Issue:6 Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cholestyramine Resin; Colesevelam Hydrochloride; Colestipol; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Prospective Studies; Treatment Outcome	2004
A bitter tale. The New England journal of medicine, 2005, Jan-06, Volume: 352, Issue:1 Topics: Anion Exchange Resins; Cholestyramine Resin; Colestipol; Digitalis; Digitoxin; Humans; Plant Poisoning	2005
Complementary care. How statin alternatives stack up. Some help control cholesterol; others are potentially harmful. Heart advisor, 2005, Volume: 8, Issue:1 Topics: Anticholesteremic Agents; Cholestyramine Resin; Colestipol; Fatty Alcohols; Humans; Niacin; Phytotherapy; Psyllium	2005
Colesevelam and colestipol: novel medication resins in the gastrointestinal tract. The American journal of surgical pathology, 2014, Volume: 38, Issue:11 Topics: Adult; Aged; Allylamine; Anticholesteremic Agents; Biopsy; Cholestyramine Resin; Colesevelam Hydrochloride; Colestipol; Female; Gastrointestinal Agents; Humans; Intestinal Mucosa; Intestines; Ion Exchange Resins; Male; Middle Aged; Prospective Studies; Risk Assessment; Risk Factors; United States	2014
Long-term outcomes in patients diagnosed with bile-acid diarrhoea. European journal of gastroenterology & hepatology, 2016, Volume: 28, Issue:2 Topics: Anion Exchange Resins; Antidiarrheals; Bile Acids and Salts; Cholestyramine Resin; Colestipol; Defecation; Diagnostic Techniques, Digestive System; Diarrhea; Drug Substitution; England; Hospitals, Teaching; Humans; Predictive Value of Tests; Retrospective Studies; Sequestering Agents; Taurocholic Acid; Time Factors; Treatment Outcome	2016
Lipid-Lowering Agents and High HDL (High-Density Lipoprotein) Are Inversely Associated With Intracranial Aneurysm Rupture. Stroke, 2018, Volume: 49, Issue:5 Topics: Adult; Aged; Aneurysm, Ruptured; Benzimidazoles; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Ezetimibe; Female; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Intracranial Aneurysm; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Oligonucleotides; PCSK9 Inhibitors; Propensity Score; Protective Factors	2018
Bile Acid Sequestrants in Microscopic Colitis: Clinical Outcomes and Utility of Bile Acid Testing. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2023, Volume: 21, Issue:12 Topics: Adult; Bile Acids and Salts; Cholestyramine Resin; Colestipol; Colitis, Microscopic; Diarrhea; Female; Humans; Male; Middle Aged	2023